BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2565975)

  • 21. Influence of dietary supplementation with olive oil on pyroglutamyl-beta-naphthylamide hydrolysing activity in serum and different tissues of mice.
    Martínez JM; Ramírez MJ; Prieto I; Alba F; Ramírez M
    Folia Biol (Praha); 1998; 44(6):213-6. PubMed ID: 10730865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of the free and Peptide forms of pyroglutamic acid in plasma from the portal blood of rats that had ingested a wheat gluten hydrolysate containing pyroglutamyl peptides.
    Higaki-Sato N; Sato K; Inoue N; Nawa Y; Kido Y; Nakabou Y; Hashimoto K; Nakamura Y; Ohtsuki K
    J Agric Food Chem; 2006 Sep; 54(19):6984-8. PubMed ID: 16968052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
    Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
    Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and identification of indigestible pyroglutamyl peptides in an enzymatic hydrolysate of wheat gluten prepared on an industrial scale.
    Higaki-Sato N; Sato K; Esumi Y; Okumura T; Yoshikawa H; Tanaka-Kuwajima C; Kurata A; Kotaru M; Kawabata M; Nakamura Y; Ohtsuki K
    J Agric Food Chem; 2003 Jan; 51(1):8-13. PubMed ID: 12502378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase.
    Podell DN; Abraham GN
    Biochem Biophys Res Commun; 1978 Mar; 81(1):176-85. PubMed ID: 26343
    [No Abstract]   [Full Text] [Related]  

  • 26. Homology modeling and site-directed mutagenesis of pyroglutamyl peptidase II. Insights into omega-versus aminopeptidase specificity in the M1 family.
    Chávez-Gutiérrez L; Matta-Camacho E; Osuna J; Horjales E; Joseph-Bravo P; Maigret B; Charli JL
    J Biol Chem; 2006 Jul; 281(27):18581-90. PubMed ID: 16611635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of some substrates and potential inhibitors of tissue pyroglutamyl aminopeptidase I.
    Svoboda KS; Currie BL
    Neuropeptides; 1992 Feb; 21(2):85-92. PubMed ID: 1348354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyroglutamyl N-termini of thermal polyamino acids.
    Melius P; Hubbard WL
    Biosystems; 1987; 20(3):213-7. PubMed ID: 2887217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation of pyroglutamyl-phenylalanyl-proline amide by a pyroglutamyl aminopeptidase purified from membrane fractions of bovine brain.
    Kelly JA; Loscher CE; Gallagher S; O'Connor B
    Biochem Soc Trans; 1997 Feb; 25(1):114S. PubMed ID: 9057012
    [No Abstract]   [Full Text] [Related]  

  • 30. Demonstration of a pyroglutamyl residue at the N terminus of the B-chain of porcine relaxin.
    Schwabe C; McDonald JK
    Biochem Biophys Res Commun; 1977 Feb; 74(4):1501-4. PubMed ID: 843375
    [No Abstract]   [Full Text] [Related]  

  • 31. Assay of pyroglutamyl aminopeptidase by high-performance liquid chromatography and its use in peptide sequencing.
    Martini F; Bossa F; Barra D
    Peptides; 1985; 6 Suppl 3():103-5. PubMed ID: 2870471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyroglutamyl peptidase: an overview of the three known enzymatic forms.
    Cummins PM; O'Connor B
    Biochim Biophys Acta; 1998 Dec; 1429(1):1-17. PubMed ID: 9920379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of pyroglutamic acid in peptides.
    Suzuki Y; Motoi H; Sato K
    J Agric Food Chem; 1999 Aug; 47(8):3248-51. PubMed ID: 10552639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prodrugs of peptides. 11. Chemical and enzymatic hydrolysis kinetics of N-acyloxymethyl derivatives of a peptide-like bond.
    Bundgaard H; Rasmussen GJ
    Pharm Res; 1991 Oct; 8(10):1238-42. PubMed ID: 1796040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New chromogenic and fluorogenic substrates for pyrrolidonyl peptidase.
    Fujiwara K; Tsuru D
    J Biochem; 1978 Apr; 83(4):1145-9. PubMed ID: 26673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of two fluorimetric assays for the determination of pyroglutamyl aminopeptidase type-II activity.
    Gallagher SP; O'Leary RM; O'Connor B
    Anal Biochem; 1997 Jul; 250(1):1-9. PubMed ID: 9234892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodrugs as drug delivery systems IV: N-Mannich bases as potential novel prodrugs for amides, ureides, amines, and other NH-acidic compounds.
    Bundgaard H; Johansen M
    J Pharm Sci; 1980 Jan; 69(1):44-6. PubMed ID: 7354439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pGlu-L-Dopa-Pro: a tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion.
    Bai JP
    Pharm Res; 1995 Jul; 12(7):1101-4. PubMed ID: 7494810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of FAB mass spectrometry and pyroglutamate aminopeptidase digestion for the structure determination of pyroglutamate in modified peptides.
    Kim J; Kim K
    Biochem Mol Biol Int; 1995 Apr; 35(4):803-11. PubMed ID: 7627130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of substrate requirements, kinetic properties, and competive inhibitors of the enzymes catabolizing TRH in rat brain.
    Busby WH; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 242(2):261-70. PubMed ID: 6126250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.